Organicell Flow

N/A

Report date: 2022/12/31 17:30:12

Base Information

Drug NameOrganicell Flow
Drug Alias NameZofin
ClassificationBiologics
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrganicell Regenerative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesZEO ScientifiX Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultCoronavirus Infections +[4] 
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A